CIK 0001437402
- Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- 4 Open-market sale President & CEO sold 6,124 shares at $0.67 ($4,112)
- 4 Open-market sale GRAMMER ELIZABETH A sold 1,263 shares at $0.67 ($848)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 1,800 shares at $0.67 ($1,206)
- 4 Open-market sale Blanks Robert sold 1,752 shares at $0.67 ($1,174)
- 4 Open-market sale President & CEO sold 6,229 shares at $0.67 ($4,173)
- 4 Open-market sale GRAMMER ELIZABETH A sold 1,528 shares at $0.67 ($1,024)
- 4 Open-market sale Chief Development Officer sold 2,353 shares at $0.67 ($1,577)
- 4 Open-market sale Chief Commercial Officer sold 3,400 shares at $0.67 ($2,278)
- 4 Grant or award Chief Development Officer acquired 55,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 42,000 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 141,000 shares (grant or award)
- 4 Grant or award Blanks Robert acquired 40,000 shares (grant or award)
- 4 Grant or award GRAMMER ELIZABETH A acquired 42,000 shares (grant or award)
- 4 Grant or award President & CEO acquired 150,000 shares (grant or award)
- 4 Open-market sale 10% owner sold 2,881,570 shares at an average $1.26 ($3,642,572)
- 4 Open-market sale 10% owner sold 2,881,570 shares at an average $1.26 ($3,642,572)
- 4 Open-market sale Chief Development Officer sold 827 shares at an average $0.99 ($820)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 16 of 35 · 696 filings